Lupin Limited has informed the Exchange regarding a press release dated January 10, 2023, titled "Lupin Receives Approval from U.S. FDA for Prasugrel Tablets, USP.".
Lupin Limited has informed the Exchange regarding a press release dated January 10, 2023, titled "Lupin Receives Approval from U.S. FDA for Prasugrel Tablets, USP.".